MetLife Investment Management’s Compass Therapeutics CMPX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $153K | Buy |
58,946
+21,779
| +59% | +$56.6K | ﹤0.01% | 2326 |
|
|
2025
Q1 | $70.6K | Sell |
37,167
-25,974
| -41% | -$49.4K | ﹤0.01% | 2645 |
|
|
2024
Q4 | $91.6K | Buy |
63,141
+42,115
| +200% | +$61.1K | ﹤0.01% | 2657 |
|
|
2024
Q3 | $38.7K | Sell |
21,026
-3,351
| -14% | -$6.17K | ﹤0.01% | 2781 |
|
|
2024
Q2 | $24.4K | Sell |
24,377
-26,153
| -52% | -$26.2K | ﹤0.01% | 2861 |
|
|
2024
Q1 | $100K | Buy |
50,530
+577
| +1% | +$1.14K | ﹤0.01% | 2538 |
|
|
2023
Q4 | $77.9K | Hold |
49,953
| – | – | ﹤0.01% | 2702 |
|
|
2023
Q3 | $98.4K | Hold |
49,953
| – | – | ﹤0.01% | 2587 |
|
|
2023
Q2 | $159K | Buy |
+49,953
| New | +$159K | ﹤0.01% | 2408 |
|